Cadila’s biosimilar at 20% of Humira price

You heard it right, the new biosimilar of adalimumab (brand name: Humira by Abbvie) was launched by Zydus Cadila with the name of Exemptia in India. This is the first biosimilar of adalimumab which is currently priced at one-fifth of Humira’s. (Read full article here) Biosimilars are significant biopharmaceutical products in  many countries in Asia. These biological products are similar, or  highly …

Obama, Shire, Abbvie

Days After AbbVie-Shire Deal, Obama Slams Tax Inverters

AbbVie recently announced intentions to acquire Shire Pharmaceuticals, and shifting their HQ to Ireland. Obama had some strong words about the practice, known as “Tax Inversion.” When a company acquires another that has business in Ireland, it is possible for that company to shift their HQ from the United States to their newly acquired assets across the Atlantic. This comes …